Search

PRELIMINARY STUDY COMPARING EFFECT OF SMOKING ON OUTCOMES OF SURGICAL AND NON-SURGICAL TREATED P16+ OROPHARYNGEAL CANCER

Oropharynx

Zaahir Turfe, MD¹, Amy Williams, PhD¹, Warren Swegal, MD¹, Francis Hall, MD¹, Steven Chang¹, Farzan Siddiqui, MD, PhD², Maria J Worsham, PhD¹, Tamer Ghanem, MD, PhD¹

¹Henry Ford Health System, Department of Otolaryngology, ²Henry Ford Health System, Department of Radiation Oncology

UNITED KINGDOM MULTICENTRE HPV OROPHARYNX CANCER CROSS-SECTIONAL STUDY - AN EVOLUTION IN THE UNDERSTANDING OF DISEASE AETIOLOGY

Oropharynx

Andrew G Schache, MD, PhD¹, Ned Powell, PhD², Kate Cuschieri, PhD³, Max Robinson, PhD⁴, Sam Leary, PhD⁵, Hisham Mehanna, MD, PhD⁶, Davy Rapozo⁷, Anna Long⁴, Heather Cubie³, Elizabeth Junor⁸, Hannah Monaghan⁹, Kevin Harrington, PhD¹⁰, Christopher M Nutting, PhD¹⁰, Ulrike Schick¹⁰, Andy S Lau¹, Jon Sheard¹, Catharine M West, PhD¹¹, Ken Oguejiofor¹¹, Steve Thomas, PhD⁵, Andy R Ness, PhD⁵, Miranda Pring⁵, Dennis J McCance, PhD¹², Jacqueline A James, PhD¹³, Michael Moran, MD, PhD¹⁴, Emma V King, PhD¹⁵, Gareth Thomas, PhD¹⁶, Phil Sloan⁴, Richard J Shaw, MD¹, Mererid Evans, MD, PhD¹⁷, Terry M Jones, MD¹

¹University of Liverpool, ²Cardiff University, ³Scottish Human Papillomavirus Reference Laboratory, ⁴Newcastle University, ⁵University of Bristol, ⁶University of Birmingham, ⁷Brazilian National Cancer Institute, ⁸Edinburgh Cancer Research Centre, ⁹Royal Infirmary of Edinburgh, ¹⁰The Royal Marsden Hospital, ¹¹University of Manchester, ¹²University of New Mexico, ¹³Northern Ireland Molecular Pathology Laboratory, ¹⁴University College London Hospital NHS Trust, ¹⁵Poole Hospital NHS Foundation Trust, ¹⁶University of Southampton, ¹⁷Velindre Cancer Centre

OCCULT MALIGNANCY IN TONSILLECTOMY SPECIMENS - WHEN TO REMOVE ASYMMETRICAL TONSILS

Oropharynx

Neil Sharma, MBChB, PhD, FRCS(ORL-HNS)¹, Paul Nankivell, BMBCh, PhD, FRCS¹, Christopher Jennings, FRCS²

¹University of Birmingham, ²University Hospital Birmingham

MULTIDISCIPLINARY TREATMENT INCLUDING SELECTIVE INTRA-ARTERIAL CISPLATIN INFUSION FOR OROPHARYNGEAL CANCER OF LATERAL WALL

Oropharynx

Yukio Nomoto, Takashi Matsuzuka, Satoshi Saijyo, Sou Sato, Hirohito Sato, Yuta Nakaegawa, Tetsuro Kobayashi, Masakazu Ikeda, Mika Nomoto, Masahiro Suzuki, Takamichi Matsui

Fukushima Medical University

TRANSORAL ROBOTIC-ASSISTED SURGERY FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA: 5-YEAR SURVIVAL ANALYSIS

Oropharynx

Julia A Crawford, MBBS, FRACS¹, Hilliary N White, MD², Thomas K Chung, MD³, Eric J Moore, MD⁴, Ryan Jackson, MD⁵, Lauren Kendall⁶, William Carroll, MD³, Eben Rosenthal, MD⁷, J Scott Magnuson, MD⁸

¹St Vincent's Hospital, Sydney, ²Baptist Medical Group, ³University of Alabama Birmingham, ⁴Mayo Clinic Rochester, ⁵Washington University, ⁶University of Central Florida, ⁷Stanford Cancer Center, ⁸Florida Hospital

ADOPTION OF TRANSORAL ROBOTIC SURGERY COMPARED WITH OTHER SURGICAL MODALITIES FOR TREATMENT OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

Oropharynx

Jennifer R Cracchiolo, MD¹, Benjamin R Roman, MD, MSHP¹, David I Kutler, MD², William I Kuhel, MD², Marc A Cohen, MD, MPH²

¹Memorial Sloan Kettering Cancer Center, ²Weill Cornell Medical College

TRANSORAL RESECTION OF HPV POSITIVE SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX: OUTCOMES WITH AND WITHOUT ADJUVANT THERAPY

Oropharynx

Ryan S Jackson, MD¹, Parul Sinha, MD¹, Joseph Zenga, MD¹, Dorina Kallogjeri, MD, MPH¹, Jasmina Suko, MSc¹, Eric J Moore, MD², Bruce H Haughey, MBChB, MS, FACS, FRACS¹

¹Washington University School of Medicine, ²Mayo Clinic

TRANSORAL ROBOTIC SURGERY FOR MANAGEMENT OF CERVICAL UNKNOWN PRIMARY SQUAMOUS CELL CARCINOMA: UPDATES ON EFFICACY, SURGICAL TECHNIQUE AND MARGIN STATUS

Oropharynx

Mathew Geltzeiler, MD, Sean Doerfler, BA, Meghan Turner, W. Greer Albergotti, MD, Mark Kubik, MD, Seungwon Kim, MD, Robert Ferris, MD, PhD, Umamaheswar Duvvuri, MD

University of Pittsburgh Medical Center

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF EXTENDED COURSE CORTICOSTEROID FOR POST-OPERATIVE PAIN CONTROL FOLLOWING TRANSORAL ROBOTIC SURGERY (TORS)

Oropharynx

Daniel Clayburgh, MD, PhD¹, Will Stott, BS¹, Rachel Bolognone, MS, CCCSLP¹, Andrew Palmer, PhD, CCCSLP¹, Virginie Achim, MD¹, Scott Troob, MD¹, Ryan Li, MD¹, Daniel Brickman, MD¹, Donna Graville, PhD, CCCSLP¹, Peter Andersen, MD¹, Neil Gross, MD²

¹Oregon Health and Science University, ²MD Anderson Cancer Center

A NEW FLEXIBLE ENDOSCOPE FOR TRANSORAL ROBOT ASSISTED SURGERY (TORS) IN HEAD AND NECK CANCER

Oropharynx

Stephan Lang, MD¹, Stefan Mattheis, MD¹, Georges Lawson, MD², Christian Güldner, MD³, Magis Mandapathil, MD³, Patrick J Schuler, MD⁴, Thomas K Hoffmann, MD⁴, Marc O Scheithauer, MD⁴, Marc Remacle, MD²

¹University Hospital of Essen, ²University Hospital of Louvain at Mont-Godinne, ³The University Hospital Giessen and Marburg, ⁴University Hospital Ulm